Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis.

CONTEXT Several studies found association between vitamin D levels and hypertension, coronary artery calcification, and heart disease. OBJECTIVE The aim of this study was to summarize the evidence on the effect of vitamin D on cardiovascular outcomes. DESIGN AND METHODS We searched electronic databases from inception through August 2010 for randomized trials. Reviewers working in duplicate and independently extracted study characteristics, quality, and the outcomes of interest. Random-effects meta-analysis was used to pool the relative risks (RR) and the weighted mean differences across trials. RESULTS We found 51 eligible trials with moderate quality. Vitamin D was associated with nonsignificant effects on the patient-important outcomes of death [RR, 0.96; 95% confidence interval (CI), 0.93, 1.00; P = 0.08], myocardial infarction (RR, 1.02; 95% CI, 0.93, 1.13; P = 0.64), and stroke (RR, 1.05; 95% CI, 0.88, 1.25; P = 0.59). These analyses were associated with minimal heterogeneity. There were no significant changes in the surrogate outcomes of lipid fractions, glucose, or diastolic or systolic blood pressure. The latter analyses were associated with significant heterogeneity, and the pooled estimates were trivial in absolute terms. CONCLUSIONS Trial data available to date are unable to demonstrate a statistically significant reduction in mortality and cardiovascular risk associated with vitamin D. The quality of the available evidence is low to moderate at best.

[1]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  G. Byrnes,et al.  Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.

[3]  H. Brenner,et al.  Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. , 2010, Preventive medicine.

[4]  A. Avenell,et al.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis , 2010, BMJ : British Medical Journal.

[5]  J. Simpson,et al.  Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.

[6]  R. Jorde,et al.  No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year , 2010, Journal of internal medicine.

[7]  Jennifer G. Robinson,et al.  Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative. , 2010, The American journal of clinical nutrition.

[8]  T. Trikalinos,et al.  Systematic Review: Vitamin D and Cardiometabolic Outcomes , 2010, Annals of Internal Medicine.

[9]  T. Trikalinos,et al.  Vitamin D and calcium: a systematic review of health outcomes. , 2009, Evidence report/technology assessment.

[10]  M. Sodemann,et al.  Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. , 2009, American journal of respiratory and critical care medicine.

[11]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[12]  J. Nagpal,et al.  A double‐blind, randomized, placebo‐controlled trial of the short‐term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle‐aged, centrally obese men , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[13]  C. Nowson,et al.  Long-term effect of calcium-vitamin D3 fortified milk on blood pressure and serum lipid concentrations in healthy older men , 2009, European Journal of Clinical Nutrition.

[14]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[15]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[16]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[17]  G. Guyatt,et al.  A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.

[18]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[19]  K. Zhu,et al.  Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. , 2008, Archives of internal medicine.

[20]  E. Michos,et al.  Vitamin D and cardiovascular disease risk , 2008, Current opinion in clinical nutrition and metabolic care.

[21]  Mikko P. Björkman,et al.  Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. , 2008, Age and ageing.

[22]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[23]  Y. Gustafson,et al.  Evaluation of a fall-prevention program in older people after femoral neck fracture: a one-year follow-up , 2008, Osteoporosis International.

[24]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[25]  J. Potter,et al.  Does vitamin D stop inpatients falling? A randomised controlled trial. , 2007, Age and ageing.

[26]  J. Manson,et al.  Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.

[27]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[28]  D. Kiel,et al.  A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.

[29]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[30]  G. Major,et al.  Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. , 2007, The American journal of clinical nutrition.

[31]  R. Newcombe,et al.  Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation , 2007, Osteoporosis International.

[32]  D. Felsenberg,et al.  Alendronate with and without cholecalciferol for osteoporosis: results of a 15‐week randomized controlled trial* , 2006, Current medical research and opinion.

[33]  D. Bunout,et al.  Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects , 2006, Experimental Gerontology.

[34]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[35]  H. Bischoff-Ferrari,et al.  Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. , 2006, Archives of internal medicine.

[36]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[37]  E. Warburton,et al.  Reduced Vitamin D in Acute Stroke , 2006, Stroke.

[38]  M. Mathieu,et al.  Clinical and laboratory safety of one year's use of acombination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: Results of a mlticenter, rndomized, double-blind, placebo-controlled study , 2005 .

[39]  J. Hopper,et al.  Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial , 2005, Journal of the American Geriatrics Society.

[40]  A. Campbell,et al.  Randomised controlled trial of prevention of falls in people aged ≥75 with severe visual impairment: the VIP trial , 2005, BMJ : British Medical Journal.

[41]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[42]  C. Cooper,et al.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial , 2005, The Lancet.

[43]  David J Torgerson,et al.  Primary care Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D 3 ) for prevention of fractures in primary care , 2005 .

[44]  J. Dumville,et al.  Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D3) for prevention of fractures in primary care , 2005 .

[45]  M. Mathieu,et al.  Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. , 2005, Clinical therapeutics.

[46]  A. Grant.  Oral vitamin D 3 and calcium for secondary prevention of low-trauma fractures in elderly people ( Randomised Evaluation of Calcium Or vitamin D , RECORD ) : a randomised placebo-controlled trial , 2005 .

[47]  A. Avenell,et al.  The effects of an open design on trial participant recruitment, compliance and retention – a randomized controlled trial comparison with a blinded, placebo-controlled design , 2004, Clinical trials.

[48]  M. Seibel,et al.  Supplementation With Oral Vitamin D3 and Calcium During Winter Prevents Seasonal Bone Loss: A Randomized Controlled Open‐Label Prospective Trial , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  K. Hamulýak,et al.  Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study , 2004, Thrombosis and Haemostasis.

[50]  R Don Gambrell,et al.  Women's Health Initiative , 2001 .

[51]  R. Harwood,et al.  A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. , 2004, Age and ageing.

[52]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[53]  Anne Moseley,et al.  A Randomized, Controlled Trial of Quadriceps Resistance Exercise and Vitamin D in Frail Older People: The Frailty Interventions Trial in Elderly Subjects (FITNESS) , 2003, Journal of the American Geriatrics Society.

[54]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[55]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[57]  M. Schlichting,et al.  Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study , 2002, Osteoporosis International.

[58]  J. I. Pedersen,et al.  Can Vitamin D Supplementation Reduce the Risk of Fracture in the Elderly? A Randomized Controlled Trial , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[60]  I. Olkin,et al.  Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement , 2000, Oncology Research and Treatment.

[61]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[62]  P. Khajehdehi.  Effect of Vitamins on the Lipid Profile of Patients on Regular Hemodialysis , 2000, Scandinavian journal of urology and nephrology.

[63]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[64]  J. Jurvelin,et al.  Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. , 1999, The Journal of clinical endocrinology and metabolism.

[65]  D. Thiebaud,et al.  Effect of Supplementation with Vitamin D3 and Calcium on Quantitative Ultrasound of Bone in Elderly Institutionalized Women: A Longitudinal Study , 1999, Osteoporosis International.

[66]  L. Baeksgaard,et al.  Calcium and Vitamin D Supplementation Increases Spinal BMD in Healthy, Postmenopausal Women , 1998, Osteoporosis International.

[67]  P. Froom,et al.  Association of calcitriol and blood pressure in normotensive men. , 1997, Hypertension.

[68]  L. Niskanen,et al.  Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. , 1997, European journal of endocrinology.

[69]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[70]  K. Khaw,et al.  Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. , 1995, European journal of clinical nutrition.

[71]  S. Saarikoski,et al.  Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. , 1995, Maturitas.

[72]  F Duboeuf,et al.  Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.

[73]  R. Morris,et al.  1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. , 1991, The Journal of clinical investigation.

[74]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[75]  A. Fleck.  LATITUDE AND ISCHAEMIC HEART DISEASE , 1989, The Lancet.

[76]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[77]  G. Gothoni,et al.  Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. , 1983, Age and ageing.

[78]  O. Grove,et al.  Relief of osteoporotic backache with fluoride, calcium, and calciferol. , 2009, Acta medica Scandinavica.

[79]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[80]  B. Jonson,et al.  Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial. , 1973, Scandinavian journal of rheumatology.